Chambal Fertilisers & Chemicals
Chambal Fertilisers & Chemicals
ChemicalsKey Fundamentals
SmallcapFertilizersChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 23.5%
Weaknesses
2- The company has delivered a poor sales growth of 10.3% over past five years.
- Debtor days have increased from 16.1 to 36.4 days.
Growth Rate
AI Analysis — Bull vs Bear
Chambal Fertilisers & Chemicals trades at a market cap of ₹16,731 Cr with a PE of 8.7x, which is low relative to broader markets. The company has maintained a consistent ROE of ~19-20% over recent years and delivered 24% compounded profit growth over three years, though sales have contracted at -9% CAGR over the same period and the stock has declined 23% in the past year.
- PE ratio of 8.7x is significantly below the broader market average, suggesting the stock is priced at a discount on an earnings basis
- Consistent ROE of 19-20% over the last 1, 3, and 5-year periods indicates efficient capital deployment and stable return generation
- Compounded profit growth of 24% over 3 years demonstrates strong earnings expansion despite top-line headwinds
- TTM sales growth of 16% signals a potential recovery in revenue momentum after a period of decline
- Dividend yield of 2.63% with a 23.5% payout ratio provides a steady income component while retaining capital for growth
- 10-year compounded profit growth of 22% and stock CAGR of 21% show a long track record of value creation
- Price-to-book ratio of 1.61x is modest for a company generating ~20% ROE, indicating the market is not pricing in a premium for earnings quality
- Stock has declined 23% over the past year, reflecting significant negative sentiment or deteriorating near-term fundamentals
- 3-year compounded sales CAGR of -9% indicates a meaningful contraction in the top line over a multi-year period
- 5-year sales growth of only 10.3% (roughly 2% annualized real growth) is poor for a mid-cap company in the chemicals space
- Debtor days have more than doubled from 16.1 to 36.4 days, signaling deteriorating working capital efficiency and potential collection issues
- 5-year compounded profit growth of just 6% suggests the recent earnings surge may not be sustainable over longer cycles
- 5-year stock CAGR of only 6% has significantly underperformed broader Indian equity indices over the same period
- As a fertiliser company, earnings are heavily influenced by government subsidy policies and urea pricing regulations, introducing policy risk that is outside management control
- 3-year stock CAGR of 14% versus 24% profit CAGR implies the market is de-rating the stock, possibly pricing in lower future growth expectations
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Commercial ammonium nitrate production Aug 21
Chambal Fertilisers commenced commercial production of Technical Ammonium Nitrate (HDAN) at its Gadepan plant, used in mining and construction explosives — a new revenue stream beyond fertilisers.
- Sustained promoter open market buying Sep 11
Promoter group entities Earthstone Holding and Hindustan Earthstone LLP have been consistently buying shares on the open market from late Aug through Sep 11, accumulating over 600,000+ shares across 12+ transactions, raising Earthstone's stake to 3.673%.
- ₹6 final dividend approved at AGM Sep 1
Shareholders approved a ₹6 per share final dividend for FY26 and re-elected director Chandra Shekhar Nopany at the AGM held September 1, 2026.
- Hindustan Earthstone builds new stake Sep 1
Hindustan Earthstone LLP, a promoter group entity, accumulated roughly 299,000 shares across four purchases between Aug 19–31, building its holding to 666,925 shares.
- Investor conference participation Aug 27
Chambal Fertilisers will participate in the Ashwamedh - Elara India Dialogue 2026 on September 2, 2026 in Mumbai for group interactions, with no unpublished price-sensitive information to be shared.
- Routine SEBI SAST disclosures filed Sep 11
Multiple promoter group share purchase disclosures were filed with NSE and BSE under SEBI SAST Regulations 2011 throughout late August and early September 2026.
TL;DR: Chambal Fertilisers shows strong promoter confidence with persistent open market buying by two group entities across August–September 2026, collectively adding significant shares. The company is diversifying beyond fertilisers with commercial HDAN production at Gadepan and rewarding shareholders with a ₹6 FY26 dividend. No headwinds are visible in the recent news flow. The trend is constructive, with promoter accumulation and business expansion signalling a positive near-term outlook.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,589 | 5,386 | 4,349 | 2,643 | 4,933 | 4,346 | 4,918 | 2,449 | 5,698 | 6,413 | 5,898 | 2,785 | 5,027 |
| Expenses | 4,956 | 4,771 | 3,720 | 2,477 | 4,181 | 3,556 | 4,140 | 2,285 | 4,937 | 5,571 | 5,078 | 2,530 | 4,201 |
| Operating Profit | 633 | 615 | 628 | 166 | 752 | 790 | 778 | 163 | 761 | 842 | 821 | 255 | 826 |
| OPM % | 11% | 11% | 14% | 6% | 15% | 18% | 16% | 7% | 13% | 13% | 14% | 9% | 16% |
| Other Income | 14 | 90 | 151 | 73 | 86 | 80 | 95 | 86 | 79 | 88 | 36 | 53 | 27 |
| Interest | 55 | 46 | 36 | 36 | 40 | 1 | 7 | 0 | 2 | 1 | 1 | 3 | 17 |
| Depreciation | 77 | 78 | 79 | 78 | 82 | 83 | 83 | 82 | 84 | 87 | 88 | 90 | 89 |
| PBT | 516 | 581 | 664 | 126 | 716 | 786 | 783 | 168 | 754 | 842 | 768 | 215 | 747 |
| Tax % | 34% | 34% | 31% | 23% | 37% | 32% | 32% | 22% | 27% | 23% | 24% | 21% | 30% |
| Net Profit | 339 | 381 | 459 | 97 | 448 | 536 | 534 | 130 | 549 | 649 | 586 | 169 | 524 |
| EPS in Rs | 8.14 | 9.15 | 11.04 | 2.42 | 11.19 | 13.39 | 13.34 | 3.25 | 13.7 | 16.19 | 14.64 | 4.22 | 13.07 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,733 | 9,008 | 7,553 | 7,541 | 10,095 | 12,206 | 12,719 | 16,069 | 27,773 | 17,966 | 16,646 | 20,794 | 20,123 |
| Expenses | 8,996 | 8,354 | 6,795 | 6,730 | 8,894 | 10,281 | 10,249 | 13,804 | 25,951 | 15,919 | 14,145 | 18,100 | 17,380 |
| Operating Profit | 737 | 654 | 759 | 811 | 1,200 | 1,925 | 2,470 | 2,265 | 1,822 | 2,047 | 2,501 | 2,694 | 2,743 |
| OPM % | 8% | 7% | 10% | 11% | 12% | 16% | 19% | 14% | 7% | 11% | 15% | 13% | 14% |
| Other Income | 103 | 32 | 133 | 172 | -2 | 192 | 470 | 374 | 222 | 326 | 329 | 240 | 203 |
| Interest | 164 | 267 | 255 | 157 | 247 | 504 | 291 | 109 | 320 | 173 | 48 | 7 | 21 |
| Depreciation | 216 | 111 | 92 | 85 | 119 | 287 | 289 | 300 | 308 | 313 | 330 | 349 | 354 |
| PBT | 459 | 308 | 544 | 740 | 832 | 1,327 | 2,360 | 2,231 | 1,416 | 1,887 | 2,452 | 2,578 | 2,572 |
| Tax % | 39% | 52% | 34% | 33% | 30% | 8% | 26% | 30% | 27% | 32% | 33% | 24% | — |
| Net Profit | 280 | 147 | 359 | 495 | 585 | 1,226 | 1,748 | 1,566 | 1,034 | 1,276 | 1,649 | 1,953 | 1,928 |
| EPS in Rs | 7.08 | 5.31 | 8.7 | 11.99 | 14.18 | 29.46 | 39.76 | 37.62 | 24.85 | 31.84 | 41.17 | 48.76 | 48.12 |
| Div. Payout % | 27% | 36% | 22% | 16% | 14% | 14% | 19% | 20% | 30% | 24% | 24% | 23% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 414 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 401 | 401 | 401 |
| Reserves | 1,837 | 1,451 | 1,707 | 2,089 | 2,467 | 3,123 | 4,833 | 5,983 | 6,652 | 6,873 | 8,327 | 10,007 |
| Borrowings | 4,089 | 5,317 | 4,619 | 6,079 | 9,045 | 10,113 | 3,936 | 4,337 | 3,358 | 1,874 | 99 | 1,068 |
| Other Liabilities | 1,298 | 939 | 1,315 | 877 | 1,997 | 880 | 1,062 | 2,553 | 2,344 | 2,361 | 2,580 | 2,927 |
| Total Liabilities | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 |
| Fixed Assets | 2,948 | 1,793 | 1,162 | 1,234 | 6,905 | 6,701 | 6,480 | 6,358 | 6,262 | 6,423 | 6,221 | 6,110 |
| CWIP | 119 | 639 | 1,712 | 4,135 | 121 | 85 | 161 | 157 | 103 | 184 | 650 | 1,389 |
| Investments | 30 | 211 | 174 | 207 | 300 | 217 | 298 | 559 | 2,377 | 2,431 | 1,372 | 1,081 |
| Other Assets | 4,541 | 5,480 | 5,009 | 3,886 | 6,598 | 7,529 | 3,308 | 6,215 | 4,028 | 2,471 | 3,164 | 5,823 |
| Total Assets | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,064 | -27 | 1,280 | 1,172 | -1,130 | 827 | 6,944 | -24 | 3,239 | 3,327 | 1,394 | 138 |
| Investing | -149 | -348 | -703 | -1,784 | -1,132 | -462 | -195 | -119 | -1,872 | -382 | 739 | -481 |
| Financing | -937 | 362 | -500 | 564 | 2,263 | -283 | -6,007 | -213 | -1,862 | -2,871 | -2,135 | 543 |
| Net Cash Flow | -22 | -12 | 76 | -49 | 2 | 82 | 742 | -356 | -495 | 73 | -2 | 200 |
| Free Cash Flow | 878 | -665 | 400 | -1,250 | -2,334 | 177 | 6,708 | -188 | 3,045 | 2,718 | 824 | -754 |
| CFO/OP | 159 | 17 | 191 | 170 | -76 | 56 | 295 | 14 | 193 | 179 | 71 | 32 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 119 | 156 | 147 | 123 | 175 | 166 | 34 | 49 | 23 | 4 | 8 | 36 |
| Inventory Days | 48 | 55 | 65 | 63 | 79 | 60 | 39 | 119 | 25 | 42 | 71 | 63 |
| Days Payable | 23 | 28 | 18 | 24 | 59 | 29 | 19 | 57 | 22 | 27 | 25 | 26 |
| Cash Conversion Cycle | 144 | 183 | 193 | 161 | 195 | 198 | 54 | 111 | 26 | 19 | 54 | 73 |
| Working Capital Days | 4 | 8 | 17 | 19 | -5 | 14 | 21 | 39 | 8 | 0 | 30 | 41 |
| ROCE % | 9% | 10% | 11% | 12% | 12% | 14% | 20% | 23% | 16% | 20% | 27% | 25% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chambal Fertilisers & Chemicals insights
61 extracted metrics + investor summaries across FY10–FY27.
Documents
Frequently Asked Questions about Chambal Fertilisers & Chemicals
What does Chambal Fertilisers & Chemicals Ltd do?
Where is Chambal Fertilisers & Chemicals Ltd (CHAMBLFERT) listed?
Which sector does Chambal Fertilisers & Chemicals Ltd belong to?
What is the market capitalisation of Chambal Fertilisers & Chemicals Ltd?
What is the PE ratio of Chambal Fertilisers & Chemicals Ltd?
What is the 52-week high and low of Chambal Fertilisers & Chemicals Ltd?
Does Chambal Fertilisers & Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Chambal Fertilisers & Chemicals Ltd?
Company Information
Chambal Fertilisers & Chemicals Ltd is engaged in production of Urea from its own manufacturing plants. It also markets/ deals in other fertilisers and agri-inputs. It also has a Joint Venture for manufacture of Phospohric Acid in Morocco. The company was also engaged in Software business, However, in FY21, it sold assets and transferred certain liabilities of the business to cease the operations of the software business.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHAMBLFERT.md for Chambal Fertilisers & Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.